Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers

• Y-mAbs Therapeutics, Inc YMAB climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter.
• Inpixon INPX jumped 37.9% to $0.5101. Inpixon reported a 21% growth in revenue to $19.4 million for the 2022 fiscal year.
• Toro Corp. TORO surged 31.6% to $3.12.
• Guardforce AI Co., Limited GFAI gained 27% to $6.00.
• IonQ, Inc. IONQ rose 25.8% to $6.39 after clocking upbeat fourth-quarter results.
• FOXO Technologies Inc. FOXO gained 24.4% to $0.4612 following full year 2022 results.
• Metropolitan Bank Holding Corp. MCB gained 23% to $31.18 after the company issued updated financial information.
• Palisade Bio, Inc. PALI gained 22% to $3.23. Maxim Group upgraded the stock from Hold to Buy and announced a $50 price target.
• Ault Alliance, Inc. AULT surged 20% to $0.1126 after the company announced a share buyback of up to 333,333,333 shares of common stock at $0.15 per sare through an exchange offer for a new class of preferred stock.
• Brainstorm Cell Therapeutics Inc. BCLI gained 19.2% to $2.98. BrainStorm Cell Therapeutics recently posted a 2022 net loss per share of $0.66.
• GT Biopharma, Inc. GTBP gained 19% to $0.55. GT Biopharma posted a FY22 loss of $0.66 per share.
• ASP Isotopes Inc. ASPI surged 18% to $1.05.
• Rigetti Computing, Inc. RGTI surged 17.8% to $0.7070. Rigetti Computing recently posted a Q1 loss of $0.19 per share.
• D-Wave Quantum Inc. QBTS climbed 15.5% to $0.60. D-Wave Quantum announced earnings report date change for Q4 and FY22 results to the week of April 10, 2023.
• Cabaletta Bio, Inc. CABA gained 14.7% to $8.15. Cabaletta Bio received FDA clearance of IND application for CABA-201 for treatment of systemic lupus erythematosus.
• Paratek Pharmaceuticals, Inc. PRTK jumped 14% to $2.4195.
• BlackBerry Limited BB gained 13.8% to $4.5550 after the company reported better-than-expected Q4 adjusted EPS results.
• Inozyme Pharma, Inc. INZY surged 13.8% to $5.34. Inozyme Pharma Director Robert Hopfner acquired a total of 344,592 shares at an average price of $4.54.
• AngioDynamics, Inc. ANGO jumped 11.4% to $10.14. AngioDynamics recently reported worse-than-expected Q3 revenue and reduced its 2023 revenue guidance.
• Marqeta, Inc. MQ rose 11% to $4.6250.
• Digital Ally, Inc. DGLY gained 9.2% to $4.16.
• TORM plc TRMD surged 8.3% to $30.90 after the company reported termination of secondary public offering of its Class A common shares by a selling shareholder.
• Digital World Acquisition Corp. DWAC gained 6.8% to $13.95 following the indictment of Donald Trump. Digital World is the business combination partner of Trump Media & Technology Group.
• Rumble Inc. RUM shares climbed 6% to $9.89 after the company reported better-than-expected Q4 results and a 142% year-over-year increase in global MAUs.

Losers

• Gorilla Technology Group Inc. GRRR dipped 66% to $4.0150.
• G Medical Innovations Holdings Ltd GMVD fell 43% to $0.9354. G Medical Innovations Holdings announced pricing of $9.6 million public offering of 12 million shares of common stock at a price of $0.80 per share.
• Virgin Orbit Holdings, Inc. VORB fell 41.4% to $0.1994 on reports the company is ceasing operations for the foreseeable future and cutting nearly 90% of its workforce.
• Chicken Soup for the Soul Entertainment, Inc. CSSE shares fell 40% to $1.9090 after the company reported Q4 results and announced pricing of $10.8 million underwritten public offering of common stock.
• Checkpoint Therapeutics, Inc. CKPT dropped 39.7% to $2.02. Checkpoint Therapeutics announced $6.1 million registered direct offering priced at-the-market under Nasdaq rules.
• Pyxis Oncology, Inc. PYXS fell 28.8% to $4.27.
• Bioventus Inc. BVS dropped 28% to $0.8721 following weaker-than-expected quarterly results.
• Biodexa Pharmaceuticals Plc BDRX dipped 27.7% to $0.3038.
• Bit Brother Limited BTB fell 24% to $0.8584.
• Professional Diversity Network, Inc. IPDN dropped 24% to $3.22.
• Ensysce Biosciences, Inc. ENSC declined 23.6% to $5.19. Ensysce Biosciences posted a Q4 loss of $1.52 per share.
• AnPac Bio-Medical Science Co., Ltd. ANPC dropped 22.7% to $4.24.
• GAN Limited GAN fell 22.4% to $1.3199 following a wider-than-expected quarterly loss.
• CuriosityStream Inc. CURI fell 22% to $1.2488 after the company reported downbeat quarterly results.
• Apollomics Inc. APLM dropped 21.8% to $23.00.
• Navidea Biopharmaceuticals, Inc. NAVB fell 21.8% to $0.25.
• AST SpaceMobile, Inc. ASTS shares fell 21.2% to $5.04 after the company posted a wider Q4 loss.
• Shapeways Holdings, Inc. SHPW fell 20.6% to $0.3255 after the company reported weaker-than-expected results for its fourth quarter.
• Annovis Bio, Inc. ANVS dipped 20.4% to $16.00. Annovis Bio received interim analysis for sample size re-estimation for its Phase 3 clinical trial for treatment of early Parkinson's disease.
• FaZe Holdings Inc. FAZE fell 20.3% to $0.47. FaZe Holdings posted Q4 sales of $21.40 million.
• ContraFect Corporation CFRX dropped 18.7% to $1.78. ContraFect posted a Q4 loss of $16.14 per share.
• Cano Health, Inc. CANO fell 17.9% to $0.9272. Cano Health said it was disappointed that three directors chose to resign.
• Charah Solutions, Inc. CHRA dropped 17.8% to $2.16.
• Nogin, Inc. NOGN fell 16.2% to $2.90.
• Siyata Mobile Inc. SYTA dropped 15.6% to $0.1595.
• Disc Medicine Opco Inc IRON fell 15% to $18.69 after the company reported full year 2022 financial results.
• Advent Technologies Holdings, Inc. ADN fell 14.6% to $0.9994. Advent Technologies reported fourth-quarter FY22 revenue of $1.96 million, down 22% year-over-year.
• Zura Bio Limited ZURA dropped 14.4% to $13.55.
• SHF Holdings, Inc. SHFS shares fell 13.4% to $0.5189. SHF Hldgs posted a Q4 loss of $1.94 per share.
• Aehr Test Systems AEHR dropped 12.5% to $32.56 following Q3 results.
• Nikola Corporation NKLA fell 12.5% to $1.22 after the company announced pricing for a $100 million common stock offering.
• E-Home Household Service Holdings Limited EJH fell 12.4% to $0.1050 after dropping 9% on Thursday.
• IGM Biosciences, Inc. IGMS fell 12% to $14.98 after the company reported Q4 financial results.
• TROOPS, Inc. TROO dropped 7.7% to $3.23.

Now Read This: Top 5 Industrials Stocks That Could Lead To Your Biggest Gains In March